Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Psoriasis drug risankizumab under Real-World spotlight for quality of life boost

NCT ID NCT07039110

Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 10 times

Summary

This study follows 700 adults with moderate-to-severe plaque psoriasis who are already prescribed risankizumab by their doctor. Researchers will track changes in quality of life, including skin symptoms and daily impacts, over up to 2.5 years. The goal is to see how well the drug works in everyday clinical practice, not just in controlled trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
risankizumab
What this could lead to
If successful, this study could confirm that risankizumab significantly improves daily life and reduces long-term social and emotional burden for people with psoriasis.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only tracks an approved drug in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 700 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult participants with moderate to severe plaque psoriasis who are prescribed risankizumab by their physician.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants with a Confirmed diagnosis of moderate-to-severe plaque psoriasis with or without joint involvement according to the treating physician's clinical judgment, prior to time of enrollment. * Treatment with risankizumab is indicated per summary of product characteristics (SmPC) or local label and local prescribing/treatment guidelines. * Decision to treat with risankizumab is made prior to and independently of study participation. Exclusion Criteria: * History of a sleep disorder diagnosis which the patient is currently being treated for. * Current or recent (within the last 30 days) participation in an interventional clinical trial or an observational study. * Currently receiving other biologic treatments and/or small molecules including Janus kinase (JAK) inhibitors, tyrosine kinase 2 (TYK2) inhibitors, and phosphodiesterase 4 (PDE4) inhibitors for any reason.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Plaque psoriasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Plaque psoriasis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    81 sites in 8 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 277341

    RECRUITING

    L’Aquila, L Aquila, 67100, Italy

  • Asahikawa Medical University Hospital /ID# 278981

    RECRUITING

    Asahikawa-shi, Hokkaido, 078-8510, Japan

  • Asklipieio General Hospital of Voula /ID# 278235

    RECRUITING

    Voula, Attica, 16673, Greece

  • Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 277713

    RECRUITING

    Naples, Napoli, 80138, Italy

  • Cca Medical Research /ID# 276944

    RECRUITING

    Ajax, Ontario, L1S 7K8, Canada

  • Centre Hospitalier Du Mans /ID# 279899

    RECRUITING

    Le Mans, Sarthe, 72037, France

  • Centre Hospitalier de Niort Georges Renon /ID# 279604

    RECRUITING

    Niort, Deux-Sevres, 79021, France

  • Centre for Medical and Surgical Dermatology /ID# 278775

    RECRUITING

    Whitby, Ontario, L1N 8M7, Canada

  • Chu de Dijon /ID# 279900

    RECRUITING

    Dijon, Bourgogne-Franche-Comté, 21000, France

  • Complejo Hospitalario Universitario de Pontevedra /ID# 278085

    RECRUITING

    Pontevedra, 36071, Spain

  • Cutaneum /ID# 277294

    RECRUITING

    Hamburg, 20249, Germany

  • Dermafit Centrum /ID# 275897

    RECRUITING

    Pilsen, Plzeň Region, 323 00, Czechia

  • Dermakulm /Id# 277864

    RECRUITING

    Kulmbach, Bavaria, 95326, Germany

  • Dermamedest /ID# 275898

    RECRUITING

    Prague, Praha 2, 120 00, Czechia

  • Dermatologie Moelln Praxis Dr. Bodo Segert /ID# 277628

    RECRUITING

    Mölln, Schleswig-Holstein, 23879, Germany

  • Dermatology Research Institute - Blackfoot Trail /ID# 276722

    RECRUITING

    Calgary, Alberta, T2J 7E1, Canada

  • Dermatrials Research /ID# 276714

    COMPLETED

    Hamilton, Ontario, L8N 1Y2, Canada

  • Dermazent /Id# 280327

    RECRUITING

    Munich, Bavaria, 80331, Germany

  • Dr. Rima Mohty /ID# 279951

    RECRUITING

    Beauvais, Oise, 60000, France

  • Dr. med. Moritz Huber und Dr. med. Martin Heister /ID# 277627

    RECRUITING

    Friedrichshafen, Baden-Wurttemberg, 88046, Germany

  • Dre Angelique Gagne-Henley M.D. inc. /ID# 276687

    RECRUITING

    Saint-Jérôme, Quebec, J7Z 7E2, Canada

  • Eternal Springtime Dermatology /ID# 278598

    RECRUITING

    Thunder Bay, Ontario, P7C 4Y7, Canada

  • Factor Dermatology /ID# 278610

    RECRUITING

    Ottawa, Ontario, K2A 2M3, Canada

  • Fakultni Nemocnice U Sv. Anny V Brne /ID# 275799

    RECRUITING

    Brno, Brno-mesto, 656 91, Czechia

  • Fakultni nemocnice Bulovka /ID# 275540

    RECRUITING

    Prague, Central Bohemia, 180 81, Czechia

  • Fakultni nemocnice Kralovske Vinohrady /ID# 275800

    RECRUITING

    Prague, 100 34, Czechia

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 278080

    RECRUITING

    Rome, Roma, 00168, Italy

  • Fukuoka University Hospital /ID# 278600

    RECRUITING

    Fukuoka, 814-0180, Japan

  • General Hospital Andreas Syggros /ID# 276826

    RECRUITING

    Athens, Attica, 16121, Greece

  • General Hospital Andreas Syggros /ID# 279246

    RECRUITING

    Athens, Attica, 16121, Greece

  • Gunma University Hospital /ID# 278497

    RECRUITING

    Maebashi, Gunma, 371-8511, Japan

  • Hautaerzte am Nauener Tor /ID# 284579

    RECRUITING

    Potsdam, Brandenburg, 14469, Germany

  • Hautarztpraxis Dr. Med. Ulrike Wiemers / Dr. Med. Franca Wiemers /ID# 277821

    COMPLETED

    Leipzig, 04317, Germany

  • Hautarztpraxis Schwelm /ID# 277464

    RECRUITING

    Schwelm, 58332, Germany

  • Hokkaido University Hospital /ID# 278260

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Hopital d'Instruction des Armees Sainte-Anne /ID# 278106

    RECRUITING

    Toulon, Var, 83800, France

  • Hopitaux Drome Nord - Romans /ID# 278109

    RECRUITING

    Romans-sur-Isère, Drome, 26102, France

  • Hospital Clinico Universitario Virgen de la Arrixaca /ID# 283338

    RECRUITING

    El Palmar, Murcia, 30120, Spain

  • Hospital General Universitario Morales Meseguer /ID# 283339

    RECRUITING

    Murcia, 30008, Spain

  • Hospital General Universitario Santa Maria Del Rosell /ID# 277894

    RECRUITING

    Cartagena, Murcia, 30203, Spain

  • Hospital Regional Universitario de Malaga /ID# 277220

    RECRUITING

    Málaga, Andalusia, 29010, Spain

  • Hospital Universitario De Toledo /ID# 277896

    RECRUITING

    Toledo, 45007, Spain

  • Hospital Universitario de Leon /ID# 277895

    RECRUITING

    León, Leon, 24080, Spain

  • Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 276488

    RECRUITING

    Thessaloniki, 54643, Greece

  • Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 276489

    RECRUITING

    Thessaloniki, 54643, Greece

  • Hosui General Medical Clinic /ID# 279520

    RECRUITING

    Sapporo, Hokkaido, 0640807, Japan

  • IRCCS Ospedale San Raffaele /ID# 277342

    RECRUITING

    Milan, Milano, 20132, Italy

  • JRB Research inc. /ID# 277730

    RECRUITING

    Ottawa, Ontario, K1K 4L2, Canada

  • Jichi Medical University Hospital /ID# 280236

    RECRUITING

    Shimotsuke-shi, Tochigi, 329-0498, Japan

  • Juntendo University Hospital /ID# 278495

    RECRUITING

    Bunkyo-ku, Tokyo, 113-8431, Japan

  • Kagoshima University Hospital /ID# 278514

    RECRUITING

    Kagoshima, Kagoshima-ken, 890-8520, Japan

  • Kawasaki Medical School Hospital /ID# 278259

    RECRUITING

    Kurashiki, Okayama-ken, 701-0192, Japan

  • Kindai University Hospital /ID# 278258

    RECRUITING

    Sakai-shi, Osaka, 590-0197, Japan

  • Klinikum Dortmund Klinikzentrum Mitte /ID# 284856

    RECRUITING

    Dortmund, North Rhine-Westphalia, 44137, Germany

  • Lovegrove Dermatology /ID# 276797

    RECRUITING

    London, Ontario, N6A 5R9, Canada

  • Lynderm Research Inc /ID# 276755

    RECRUITING

    Markham, Ontario, L3P 1X2, Canada

  • Nemocnice Ceske Budejovice /ID# 275541

    RECRUITING

    České Budějovice, 370 01, Czechia

  • Nihon University Itabashi Hospital /ID# 279916

    RECRUITING

    Tokyo, 173-8610, Japan

  • Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 278434

    RECRUITING

    Osaka, 550-0006, Japan

  • North York Research /ID# 276835

    RECRUITING

    Toronto, Ontario, M2N 3A6, Canada

  • Ospedale San Martino /ID# 278984

    RECRUITING

    Genova, 16132, Italy

  • Papageorgiou General Hospital /ID# 276487

    RECRUITING

    Thessaloniki, 56429, Greece

  • Private Practice - Dr. Mario Pawlak /ID# 277465

    RECRUITING

    Heilbad Heiligenstadt, 37308, Germany

  • Quinte dermatology /ID# 277497

    RECRUITING

    Belleville, Ontario, K8N 2S9, Canada

  • Rejuvenation Dermatology - Edmonton Downtown /ID# 276688

    RECRUITING

    Edmonton, Alberta, T5J 3S9, Canada

  • Rejuvenation Dermatology Clinic Oakville /ID# 277492

    RECRUITING

    Oakville, Ontario, L6H 6P8, Canada

  • SKiN Centre for Dermatology /ID# 277594

    RECRUITING

    Peterborough, Ontario, K9J 5K2, Canada

  • Seibo Hospital /ID# 279522

    RECRUITING

    Shinjuku-ku, Tokyo, 161-8521, Japan

  • Teikyo University Hospital /ID# 278228

    RECRUITING

    Tokyo, 173-8605, Japan

  • The University Hospital of Larissa /ID# 276576

    RECRUITING

    Larissa, Thessaly, 41110, Greece

  • The University of Osaka Hospital /ID# 278436

    RECRUITING

    Suita-shi, Osaka, 565-0871, Japan

  • Tokai University Hospital /ID# 278294

    RECRUITING

    Isehara, Kanagawa, 259-1193, Japan

  • Tokyo Yamate Medical Center /ID# 278960

    RECRUITING

    Tokyo, 169-0073, Japan

  • Toronto Dermatology Centre /ID# 276846

    RECRUITING

    Toronto, Ontario, M3H 5Y8, Canada

  • Tzaneio Prefecture General Hospital of Piraeus /ID# 276532

    RECRUITING

    Piraeus, Attica, 18536, Greece

  • Universitaetsklinikum Hamburg-Eppendorf /ID# 277164

    RECRUITING

    Hamburg, 20246, Germany

  • Universitaetsmedizin Mainz /ID# 278229

    RECRUITING

    Mainz, Rhineland-Palatinate, 55131, Germany

  • University General Hospital Attikon /ID# 278389

    RECRUITING

    Chaïdári, Attica, 12462, Greece

  • University Hospital Kyoto Prefectural University of Medicine /ID# 278962

    RECRUITING

    Kyoto, Kyoto, 602-8566, Japan

  • University of the Ryukyus Hospital /ID# 278256

    RECRUITING

    Ginowan-shi, Okinawa, 901-2725, Japan

  • Winnipeg Clinic /ID# 276751

    RECRUITING

    Winnipeg, Manitoba, R3C 1T6, Canada

  • Wiseman Dermatology Research /ID# 276847

    RECRUITING

    Winnipeg, Manitoba, R3M 3Z4, Canada

  • Yokohama City University Hospital /ID# 278257

    RECRUITING

    Yokohama, Kanagawa, 236-0004, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.